Published in J Biol Chem on March 26, 1999
Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev (2011) 2.48
Phospholipase A2 biochemistry. Cardiovasc Drugs Ther (2008) 1.93
The metabolic serine hydrolases and their functions in mammalian physiology and disease. Chem Rev (2011) 1.89
Role of group V phospholipase A2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J Biol Chem (2004) 1.66
Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis. J Biol Chem (2006) 1.41
Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J Biol Chem (2006) 1.20
Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells. J Biol Chem (2005) 1.13
Characterization of a novel inhibitor of cytosolic phospholipase A2alpha, pyrrophenone. Biochem J (2002) 1.11
A bromoenol lactone suicide substrate inactivates group VIA phospholipase A2 by generating a diffusible bromomethyl keto acid that alkylates cysteine thiols. Biochemistry (2006) 1.10
Attenuated free cholesterol loading-induced apoptosis but preserved phospholipid composition of peritoneal macrophages from mice that do not express group VIA phospholipase A2. J Biol Chem (2007) 1.10
Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol (2010) 1.01
Function, activity, and membrane targeting of cytosolic phospholipase A(2)zeta in mouse lung fibroblasts. J Biol Chem (2007) 0.99
PLA2 activity is required for nuclear shrinkage in caspase-independent cell death. J Cell Biol (2003) 0.97
Phospholipase A2 functions in Pseudomonas aeruginosa-induced apoptosis. Infect Immun (2006) 0.96
The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes. Br J Pharmacol (2000) 0.95
Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). J Exp Med (2002) 0.93
Expression of phospholipases A2 and C in human corneal epithelial cells. Invest Ophthalmol Vis Sci (2004) 0.92
Effects of biological oxidants on the catalytic activity and structure of group VIA phospholipase A2. Biochemistry (2006) 0.92
Human cytomegalovirus carries a cell-derived phospholipase A2 required for infectivity. J Virol (2004) 0.91
Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids. Biochim Biophys Acta (2009) 0.89
Interfacial kinetic and binding properties of mammalian group IVB phospholipase A2 (cPLA2beta) and comparison with the other cPLA2 isoforms. J Biol Chem (2010) 0.88
Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology (Berl) (2008) 0.86
Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology (Berl) (2008) 0.86
Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory. Psychopharmacology (Berl) (2005) 0.85
Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly. J Virol (2012) 0.85
Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death. J Neurochem (2008) 0.84
Arachidonate release and prostaglandin production by group IVC phospholipase A2 (cytosolic phospholipase A2gamma). Biochem J (2003) 0.83
Group IVC cytosolic phospholipase A2gamma is farnesylated and palmitoylated in mammalian cells. J Lipid Res (2005) 0.82
Group V secretory phospholipase A2 amplifies the induction of cyclooxygenase 2 and delayed prostaglandin D2 generation in mouse bone marrow culture-derived mast cells in a strain-dependent manner. Biochim Biophys Acta (2006) 0.80
The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis? Vasc Health Risk Manag (2008) 0.80
Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in rats. J Neural Transm (Vienna) (2006) 0.79
Polychlorinated biphenyls induce arachidonic acid release in human platelets in a tamoxifen sensitive manner via activation of group IVA cytosolic phospholipase A2-alpha. Biochem Pharmacol (2005) 0.78
Interferon gamma-induced gene expression of the novel secretory phospholipase A2 type IID in human monocyte-derived macrophages is inhibited by lipopolysaccharide. Inflammation (2005) 0.78
Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus. J Neural Transm (Vienna) (2014) 0.76
Conditioning training and retrieval increase phospholipase A(2) activity in the cerebral cortex of rats. J Neural Transm (Vienna) (2008) 0.75
Inhibition of phospholipase A(2) activity by conjugated linoleic acids in human macrophages. Eur J Nutr (2006) 0.75
Purification and characterization of a cytosolic Ca(2+)-independent phospholipase A(2) from bovine brain. Mol Cells (2011) 0.75
Effect of allergy and inflammation on eicosanoid gene expression in CFTR deficiency. J Cyst Fibros (2012) 0.75
A radioimmunoassay for rat plasma ACTH. Endocrinology (1971) 3.35
Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc Natl Acad Sci U S A (1981) 2.96
Functional and structural diversity of the human Dickkopf gene family. Gene (1999) 2.82
Altered enzymes in drug-resistant variants of mammalian tissue culture cells. Proc Natl Acad Sci U S A (1973) 2.24
Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA. Cancer Res (1989) 1.62
Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat. Stroke (1996) 1.59
Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett (1997) 1.39
The incidence of impacted teeth. A survey at Harlem hospital. Oral Surg Oral Med Oral Pathol (1970) 1.35
Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem (1995) 1.28
Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest (1995) 1.24
Identification of essential residues for the catalytic function of 85-kDa cytosolic phospholipase A2. Probing the role of histidine, aspartic acid, cysteine, and arginine. J Biol Chem (1996) 1.16
Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem (1997) 1.15
Metal ion and salt effects on the phospholipase A2, lysophospholipase, and transacylase activities of human cytosolic phospholipase A2. Biochim Biophys Acta (1993) 1.14
Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution. Nature (1991) 1.13
Arachidonoyl transacylase in human platelets. Coenzyme A-independent transfer of arachidonate from phosphatidylcholine to lysoplasmenylethanolamine. J Biol Chem (1983) 1.13
Cytosolic phospholipase A2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J Biol Chem (1995) 1.09
Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells. J Biol Chem (1998) 1.06
Metabolism of platelet-activating factor in human platelets. Transacylase-mediated synthesis of 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. J Biol Chem (1984) 1.05
Cardiac-specific phosphorylation site for multifunctional Ca2+/calmodulin-dependent protein kinase is conserved in the brain ryanodine receptor. J Biol Chem (1992) 1.01
Solubilization and properties of Ca2+-dependent human platelet phospholipase A2. Biochim Biophys Acta (1986) 1.00
Effects of group identity on resource use in a simulated commons dilemma. J Pers Soc Psychol (1984) 1.00
Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. DNA Cell Biol (2000) 0.98
Validation of the redox cytochemical assay for corticotrophin. Clin Endocrinol (Oxf) (1974) 0.93
Coenzyme A-mediated arachidonic acid transacylation in human platelets. J Biol Chem (1984) 0.92
Serine 228 is essential for catalytic activities of 85-kDa cytosolic phospholipase A2. J Biol Chem (1994) 0.91
Recent insights into the structure, function and biology of cPLA2. Agents Actions Suppl (1995) 0.89
Interruption of DNA injection by x-irradiation of phage lambda. Virology (1971) 0.88
Lack of polarity of DNA injection by Escherichia coli phage lambda. Virology (1971) 0.88
The effect of acute or chronic ether stress on plasma ACTH concentration in the rat. Endocrinology (1973) 0.87
Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes. Brain Res (1994) 0.87
Transbilayer mapping of membrane proteins using membranes isolated on polylysine-coated polyacrylamide beads. Biochim Biophys Acta (1980) 0.87
Cross-talk between secretory phospholipase A2 and cytosolic phospholipase A2 in rat renal mesangial cells. Biochim Biophys Acta (1997) 0.87
The neuronal ceroid-lipofuscinoses. Recent advances. Brain Pathol (1998) 0.86
Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets. Biochem J (1996) 0.85
Rapid transmembrane movement of phosphatidylcholine in small unilamellar lipid vesicles formed by detergent removal. Biochim Biophys Acta (1981) 0.83
Pancreatic-type phospholipase A2 induces group II phospholipase A2 expression and prostaglandin biosynthesis in rat mesangial cells. J Biol Chem (1994) 0.83
Phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in MCII mast cells mediated by high-affinity Fc receptor for IgE. Biochem J (1994) 0.82
A new locus for variant late infantile neuronal ceroid lipofuscinosis-CLN7. Mol Genet Metab (1999) 0.82
Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8. Eur J Paediatr Neurol (2001) 0.81
Applications of the redox bioassay for luteinizing hormone. Clin Endocrinol (Oxf) (1974) 0.81
Effect of membrane cholesterol on phospholipid metabolism in thrombin-stimulated platelets. Enhanced activation of platelet phospholipase(s) for liberation of arachidonic acid. J Biol Chem (1982) 0.81
Assay and purification of phospholipase A2 from human synovial fluid in rheumatoid arthritis. Methods Enzymol (1991) 0.80
Comparison of the redox bioassay with other assays for luteinizing hormone. J Endocrinol (1976) 0.80
Expression, purification and biochemical comparison of natural and recombinant human non-pancreatic phospholipase A2. Biochem Biophys Res Commun (1992) 0.79
Ocular absorption of indomethacin by the rabbit. Arch Ophthalmol (1972) 0.79
Human group II 14 kDa phospholipase A2 activates human platelets. Biochem J (1997) 0.79
Cytosolic phospholipase A2 (cPLA2) distribution in murine brain and functional studies indicate that cPLA2 does not participate in muscarinic receptor-mediated signaling in neurons. Brain Res (1998) 0.78
Molecular characterization of the Pseudomonas syringae pv. pisi plasmid-borne avirulence gene avrPpiB which matches the R3 resistance locus in pea. Mol Plant Microbe Interact (1995) 0.78
Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors. Eur J Pharmacol (1996) 0.78
Retention of lipid asymmetry in membranes on polylysine-coated polyacrylamide beads. Biochim Biophys Acta (1979) 0.78
Technical aspects of the redox bioassay for luteinizing hormone. Clin Endocrinol (Oxf) (1974) 0.78
Enhancement of insulin release to acute glycaemic stimulation with depression of basal insulin production rates in insulinoma following diazoxide administration. Acta Endocrinol (Copenh) (1970) 0.78
Teaching dental students a proper way of introducing patients to instructors. J Dent Educ (1984) 0.75
Proceedings: Modifications of the redox bioassay of luteinizing hormones. J Endocrinol (1974) 0.75
Report of the fourth international workshop on human chromosome 15 mapping 1997. Cytogenet Cell Genet (1999) 0.75
The relationship between arthritic adults and furniture usage: a study. Rehabil Lit (1984) 0.75
Contracting with nonprofits. Public Welf (1984) 0.75
Exclusion mapping of classical late infantile neuronal ceroid lipofuscinosis (Jansky-Bielschowsky disease, CLN2) Eur J Hum Genet (1995) 0.75
The future of the voluntary agency in a mixed economy. J Appl Behav Sci (1985) 0.75
The importance of stimulus intensity and duration of steroid administration in suppression of stress-induced ACTH secretion. Endocrinology (1972) 0.75
Voluntary agencies in four welfare states. Adm Soc Work (1979) 0.75